Phoenix staff, wire report
Oklahoma ace Jonathan Gray, who is projected to be a top-five selection in this week’s Major League Baseball draft, tested positive for Adderall during a predraft drug testing program, ESPN.com reported on Monday.
Adderall comprises salts of two amphetamines and is banned by MLB unless used therapeutically. Multiple sources told ESPN.com that Gray did not have a prescription for the drug, the website reported.
According to the NCAA website, stimulants are a banned substance. Adderall is listed by the NCAA as an amphetamine in the stimulants’ drug class.
Oklahoma released a statement late Monday afternoon saying Gray remains eligible to compete with the baseball program. The Sooners — who have won all seven of their postseason games — will play at LSU in a Super Regional this weekend with a berth in the College World Series at stake.
“All University of Oklahoma student-athletes are subject to institutional and NCAA drug testing and are subject to corrective action relative to those policies,” the statement read. “At this time, we are able to confirm that Jonathan Gray is eligible to compete for the University of Oklahoma baseball program.”
Oklahoma has won all seven of its postseason games. Gray’s most recent game was a complete-game, 11-strikeout effort in a 7-3 win over Coastal Carolina in the Blacksburg (Va.) Regional, in which he was named to the all-region team.
The Chandler native has been dominant throughout his junior season, going 10-2 with a 1.59 ERA. He has thrown 119 innings this season, registering 138 strikeouts. The right-hander was the Big 12 Tournament’s most outstanding player and
Adderall use without an exemption is prohibited by MLB, with players typically receiving a 25-game ban for a second positive test.